NextCure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.About NXTC
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines.
CEOMichael S. Richman
CEOMichael S. Richman
Employees43
Employees43
HeadquartersBeltsville, Maryland
HeadquartersBeltsville, Maryland
Founded2015
Founded2015
Employees43
Employees43
NXTC Key Statistics
Market cap156.05M
Market cap156.05M
Price-Earnings ratio-0.22
Price-Earnings ratio-0.22
Dividend yield—
Dividend yield—
Average volume19.91K
Average volume19.91K
High today$4.93
High today$4.93
Low today$4.76
Low today$4.76
Open price$4.82
Open price$4.82
Volume27.51K
Volume27.51K
52 Week high$21.84
52 Week high$21.84
52 Week low$2.69
52 Week low$2.69
NXTC News
TipRanks 2d
NextCure Implements Reverse Stock Split on NasdaqElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own NXTC. This list is generated using Robinhood data, and it’s not a recommendation.